Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multimodality therapy for sleep apnea syndromes.

Literature DB >> 23066369

Multimodality therapy for sleep apnea syndromes.

Robert Joseph Thomas¹.

Abstract

Entities: Disease

Mesh：

Year: 2012 PMID： 23066369 PMCID： PMC3459203 DOI： 10.5664/jcsm.2158

Source DB: PubMed Journal: J Clin Sleep Med ISSN： 1550-9389 Impact factor: 4.062

Keyword Cloud
References

× No keyword cloud information.

13 in total

1. A method for measuring and modeling the physiological traits causing obstructive sleep apnea.

Authors: Andrew Wellman; Danny J Eckert; Amy S Jordan; Bradley A Edwards; Chris L Passaglia; Andrew C Jackson; Shiva Gautam; Robert L Owens; Atul Malhotra; David P White
Journal: J Appl Physiol (1985) Date: 2011-03-24

2. Treatment of positive airway pressure treatment-associated respiratory instability with enhanced expiratory rebreathing space (EERS).

Authors: Geoffrey Gilmartin; Brennden McGeehan; Kevin Vigneault; Robert W Daly; Megan Manento; J Woodrow Weiss; Robert Joseph Thomas
Journal: J Clin Sleep Med Date: 2010-12-15 Impact factor: 4.062

3. The effect of zolpidem on sleep quality, stress status, and nondipping hypertension.

Authors: Yuli Huang; Weiyi Mai; Xiaoyan Cai; Yunzhao Hu; Yuanbin Song; Ruofeng Qiu; Yanxian Wu; Jian Kuang
Journal: Sleep Med Date: 2011-12-06 Impact factor: 3.492

4. Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep-disordered breathing.

Authors: C W Braga; Q Chen; O E Burschtin; D M Rapoport; I Ayappa
Journal: J Appl Physiol (1985) Date: 2011-07-28

Review 5. Pathophysiology of sleep apnea.

Authors: Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal: Physiol Rev Date: 2010-01 Impact factor: 37.312

10. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.

Authors: Richard B Berry; Meir H Kryger; Clifford A Massie
Journal: Sleep Date: 2011-04-01 Impact factor: 5.849

Multimodality therapy for sleep apnea syndromes.

1. A method for measuring and modeling the physiological traits causing obstructive sleep apnea.

2. Treatment of positive airway pressure treatment-associated respiratory instability with enhanced expiratory rebreathing space (EERS).

3. The effect of zolpidem on sleep quality, stress status, and nondipping hypertension.

4. Changes in lung volume and upper airway using MRI during application of nasal expiratory positive airway pressure in patients with sleep-disordered breathing.

Review 5. Pathophysiology of sleep apnea.

6. Improvement of idiopathic central sleep apnea with zolpidem.

7. Treatment of central sleep apnea in U.S. veterans.

8. Effect of continuous positive airway pressure on sleep structure in heart failure patients with central sleep apnea.

9. A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.

10. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial.